NCT04209218View on ClinicalTrials.gov

Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery

NARecruitingINTERVENTIONAL
Enrollment

1,988

Participants

Timeline

Start Date

April 7, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2029

Conditions
Lung CancerSurgeryBlood Pressure ManagementDexamethasoneOverall SurvivalPostoperative Complications
Interventions
DRUG

Dexamethasone

Dexamethasone (10 mg/2 ml) is administered before anesthesia induction.

OTHER

Targeted blood pressure management

Blood pressure is maintained within ±10% from baseline.

DRUG

Placebo

Placebo (2 ml normal saline) is administered before anesthesia induction.

OTHER

Routine blood presure management

Blood pressure is maintained according to routine practice.

Trial Locations (1)

100034

RECRUITING

Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER